Ispecimen Inc. (ISPC)
NASDAQ · Healthcare
Ispecimen Inc. EBITDA 2020–2025
Ispecimen Inc. annual/quarterly ebitda history and growth rate from 2023 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Ispecimen Inc. ebitda for the quarter ending March 31, 2026 was -2.4 M, a 99.26% increase year-over-year.
- Ispecimen Inc. annual ebitda for 2025 was -7.2 M, a 30.54% decrease from 2024.
- Ispecimen Inc. annual ebitda for 2024 was -10.4 M, a 15.24% increase from 2023.
- Ispecimen Inc. annual ebitda for 2023 was -9.1 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ispecimen Inc. EBITDA — FAQ
Ispecimen Inc. (ISPC) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ISPC's ebitda history?
The chart and table above show Ispecimen Inc.'s ebitda by year and by quarter, including the growth rate.